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Introduction
It is widely accepted that exposing patients to unneces-
sary ionizing radiation falls below the standard of  care. It is  
our responsibility as radiologists to eliminate excessive ra-
diation exposure and to protect our patients. The recent 
advances in multidetector computed tomography (MDCT) 
have allowed the development of  numerous imaging proto-
cols that were not available 10-15 years ago. Dedicated liver 
imaging is an area of  radiology that has benefited from 
these advances. Many new liver imaging protocols have 
been established and deemed valuable in the radiologists’ 
arsenal for increasing the sensitivity and specificity of  their 
diagnosis. However, the value of  including each new proto-
col for every patient raises many questions.
It is estimated that the median effective dose for a non-
contrast and three-phasic liver CT exam is 31 millisievert 
(mSv) (range, 21-43), with an absolute range of  6-90 mSv. 
31 mSv is equivalent to 442 chest x-rays, 74 mammograms, 
or 15 years of  background radiation exposure (1). Many of  
the patients undergoing liver-specific imaging require mul-
tiple followup studies, which further increase their radiation 
exposure. 
We evaluated our current liver-specific CT protocols to 
reduce radiation dose while maintaining a high degree of  
diagnostic accuracy. Our study showed that a 30-40% dose 
reduction could be achieved by eliminating the nonen-
hanced acquisition and by employing conscientious “Z-
creep” (tight scan window flanking the liver, to avoid scan-
ning unnecessary parts of  the abdomen) while maintaining 
a high degree of  specificity and sensitivity. 
The standard MDCT liver imaging protocol at the VA 
Puget Sound Healthcare System (VAPSHCS) includes four 
different acquisitions, a noncontrast scan, and three addi-
tional scans with the use of  iodinated contrast. These ac-
quisitions are obtained by scanning the patient from just 
above the diaphragm to the top of  the iliac crests, as 
follows: 
1 Nonenhanced scan without contrast
2 Enhanced arterial phase (20-30 seconds)
3 Portal-venous phase (60-70 seconds)
4 10-minute delay 
By using these four separate acquisitions, the radiologist 
can achieve diagnostic sensitivity and specificity in the mid-
to-upper-90th percentile for detection of  liver masses (2). 
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While improving diagnostic accuracy is optimal, the value 
of  each acquisition has been called into question as we be-
come more aware of  the negative effects of  ionizing radia-
tion. We feel that the routine use of  a nonenhanced acquisi-
tion is no longer necessary for all patients, and by eliminat-
ing this acquisition in the majority of  our patients, we ex-
pect to reduce radiation exposure. 
Situations where a nonenhanced acquisition would be 
added are as follows:
• The patient is new, and baseline nonenhanced liver 
imaging has not been already performed.
• The patient has undergone recent hepatic arterial 
chemoembolization or radiofrequency ablation (RFA), 
which can be difficult, as it involves evaluation of  high-
density embolization material or coagulation necrosis on 
contrast-enhanced acquisitions.
Additionally, by altering the scanning window from the 
standard “diaphragm to iliac crest” to include only the area 
of  the abdomen occupied by the liver (also known as "con-
scientious Z-creep"), we can reduce radiation exposure to 
the patient. By changing the way we acquire the images for 
liver specific MDCTs, we can reduce radiation dose by 30-
40%. 
Methods
Prospective data was collected at the VAPSHCS on a 
total of  nine patients who were referred for hepatic mass 
evaluation. This Health Insurance Portability and Ac-
countability Act (HIPAA)-compliant study was approved by 
the departmental quality assurance/quality initiative (QA/
QI) committee. The need to obtain informed consent was 
waived. All underwent multiphasic liver-mass MDCT ex-
ams. A subset of  three patients were imaged using the stan-
dard four-phase protocol established at our institution, with 
the field of  view from the diaphragm to iliac crests. This 
subset included new patients, without prior liver CTs or 
recent chemo-embolization. A second subset of  three pa-
tients underwent a four-phase MDCT for liver-mass 
evaluation; however, the field-of-view imaging parameters 
were manipulated to include only the liver area of  the ab-
domen (to employ conscientious Z-creep). These patients 
were scanned from the diaphragm to inferior liver. A third 
subset of  three patients underwent a three-phase MDCT 
without the nonenhanced acquisition, and the field of  view 
was flanked to employ conscientious Z-creep. Treatment for 
this group of  patients included followup exams, with prior 
nonenhanced liver CTs on record. Radiation-dose data was 
collected for each CT series acquisition, and the total effec-
tive dose was calculated for each patient. Total effective 
dose was calculated using the “K” factors supplied by the 
American Association of  Physicists in Medicine (AAPM).
Results
Our study revealed a 30% dose reduction in patient 
groups that were subject to conscientious adjustment of  Z-
creep, compared to the standard diaphragm-to-crest scan-
ning window. A 30% dose reduction was also observed in 
the patient group who underwent a three-phase scan plus 
use of  conscientious Z-creep. However, we did not see any 
significant dose reduction between the conscientious Z-
creep-adjusted group and the three-phase-plus-Z-creep 
group (Table, Figs. 1, 2). 
Table: Cumulative dose in multiphase liver CT performed on nine 
patients
Patient subset Radiation (mSv)
4 phases: Diaphragm to iliac 
crest. n=3
31.9
4 phases: Diaphragm to lowest 
liver edge. n=3
22.3
3 phases: Diaphragm to lowest 
liver edge (noncontrast not per-
formed). n=3
22.1
Discussion
Thoughtful and specific protocoling can reduce the 
amount of  radiation exposure for the patient and can im-
prove efficiency within the radiology department. CT use 
has increased significantly over the past several decades, 
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Figure 1. Dose reduction with flanking and eliminating the 
nonenhanced acquisition. A 30% radiation dose reduction 
was achieved between the standard 4-phase liver mass 
MDCT protocol (purple column) and the implemention of 
conscientious Z-creep (tight flanking of the field of view) 
(green column). Eliminating the nonenhanced acquisition 
plus implementing conscientious Z-creep also produced a 
30% reduction in dose (gold column) when compared to the 
standard four-phase protocol.
and it is important to limit the amount of  radiation expo-
sure to patients whenever possible (1). 
In a study by Miller et al (2), 584 liver lesions were de-
tected using dedicated liver imaging in 102 different pa-
tients. The authors evaluated the usefulness of  the nonen-
hanced study and found that no lesions were visualized 
using only the nonenhanced study. Nonenhanced exams 
have decreased sensitivity for detection of  small lesions, 
often due to difficulty in differentiation from unopacified 
vessels or biliary dilatation. The authors concluded that a 
nonenhanced study should not be routinely used for hepa-
tocellular carcinoma or metastases evaluation. A second 
study by Oliver et al (3) had similar findings. In their popu-
lation, they discovered that 3% (2/81) of  patients had le-
sions that were detected on the nonenhanced acquisition 
only. The lesions that were not detected on the arterial or 
portal venous phases at the time of  the study were nonen-
hancing and hyper-cellular. In both studies, delayed acquisi-
tions were not acquired. The combination of  all three 
phases yields the greatest diagnostic performance, particu-
larly in small HCCs (smaller than 2 cm), which typically are 
more conspicuous on the delayed-phase images than on 
portal-venous-phase images (4). However, the routine use of 
a nonenhanced acquisition is unnecessary. 
For our protocol, if  the patient had previous nonen-
hanced imaging of  the liver, a nonenhanced study was not 
repeated. An exception was if  the patient had recently un-
dergone chemo-embolization or RFA; in that case, they 
received a nonenhanced phase as well. The optimal study 
to evaluate postembolization patients is contrast-enhanced 
magnetic resonance imaging (MRI). If  MRI is contraindi-
cated in a patient, a four-phase CT is the next best option. 
Postembolization material and coagulation necrosis can be 
hyperdense on CT and lead to confusion differentiating 
between embolization material and true enhancement. 
Our data revealed a 30% dose reduction in patients that 
were subject to conscientious Z-creep elimination, com-
pared to the standard diaphragm-to-crest scanning window. 
While it is reasonable to conclude that dose reduction 
would occur by eliminating the scanning of  non-liver-
containing abdomen, it is curious that there was no differ-
ence between the patients who received a tightly flanked 
three- or four-phase study. This can be explained by the 
lack of  power in our data and the variables of  patient and/
or liver size. In both patients who only had a three-phase 
acquisition study, the average Z-axis length was 32.3cm, 
but in the patients who had a nonenhanced study, the aver-
age Z-axis was 25cm. If  we had a larger sample size, we are 
confident that difference in patient size would equal out 
and a significant difference in total effective dose would be 
accomplished. 
A four-phase contrast-enhanced liver protocol MDCT is 
one of  highest radiation-dosed studies in the radiology rep-
ertoire. Frequently, the patients receiving this study require 
multiple followup examinations, which can result in a very 
large cumulative exposure. Radiation dose reduction is a 
worthy goal, and by making two simple-to-implement 
changes, we can improve patient care and improve the effi-
ciency of  the radiology department.
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Figure 2. Percent decrease in total effective radiation dose. 
The total effective radiation dose was reduced between 
patient subsets through the adjustment of scan parameters 
and the use of patient-specific protocoling.
